IVF HARTMANN HOLDING AG CHF1.75 (REGD)II

IVF HARTMANN HOLDING AG CHF1.75 (REGD)

146CHFD
+1+0.69%
At close at Mar 6, 16:01 GMT
CHF
No trades
See on Supercharts

0QQM fundamentals

Key facts

Market capitalization‪332.45 M‬CHF
Founded1871
CEOClaus Martini
About

IVF HARTMANN Holding AG engages in the business of producing and distributing medical consumer products. It operates through the following segments: Wound Care, Incontinence Management, Infection Management, and Other Group Activities. The Wound Care segment includes modern and traditional wound care products, as well as the first aid product area. The Incontinence Management segment offers products of incontinence, patient hygiene, and medical skin care product range. The Infection Management segment includes disinfectants, surgical drapes, surgical clothing and gloves, disposable surgical instruments, and customer-specific sets. The Other Group Activities segment is involved in various cotton wool, personal care, housekeeping, hygiene products, and product area of self-diagnostics. The company was founded in 1871 and is headquartered in Neuhausen, Switzerland.

Ownership
‪‪2.38 M‬‬
Closely held shares
‪‪1.76 M‬‬ (74.01%)
Free Float shares
‪‪619.07 K‬‬ (25.99%)
Closely held shares
‪‪1.76 M‬‬ (74.01%)
Free Float shares
‪‪619.07 K‬‬ (25.99%)
Capital structure
Market cap
‪‪332.45 M‬‬
Enterprise value
‪‪332.45 M‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪332.45 M‬‬
Price to earning ratio (P/E)
Price to sales ratio (P/S)
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
Price to sales ratio (P/S)
Valuation ratios
‪0.00‬
‪0.55‬
‪1.10‬
‪1.65‬
‪2.20‬
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
‪0.00‬
‪7.00‬
‪14.00‬
‪21.00‬
‪28.00‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪7.5%‬
‪9.0%‬
‪10.5%‬
‪12.0%‬
‪13.5%‬
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
‪0.00‬
‪‪21.00 M‬‬
‪‪42.00 M‬‬
‪‪63.00 M‬‬
‪‪84.00 M‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪‪−140.00 M‬‬
‪‪−70.00 M‬‬
‪0.00‬
‪‪70.00 M‬‬
‪‪140.00 M‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪‪−140.00 M‬‬
‪‪−70.00 M‬‬
‪0.00‬
‪‪70.00 M‬‬
‪‪140.00 M‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2024
Infection Management
Wound Care
Incontinence Management
Other
By country
Period: 2024
Switzerland
Foreign

Dividends

Dividend yield, history and sustainability

Dividend summary
37.83%
Earnings retained
Payout ratio (TTM)
Dividend yield TTM
2.29%
Next payment
6.20
Next ex-date
Apr 17, 2025
Dividend history
‪1.0%‬
‪1.5%‬
‪2.0%‬
‪2.5%‬
‪3.0%‬
2020
2021
2022
2023
2024
‪0.00‬
‪0.80‬
‪1.60‬
‪2.40‬
‪3.20‬
Dividends per share (FY)
Dividend yield (FY) %

Financial health

Financial position and solvency of the company

Debt level and coverage
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
‪0.00‬
‪‪25.00 M‬‬
‪‪50.00 M‬‬
‪‪75.00 M‬‬
‪‪100.00 M‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
No data available
There's currently no assets and liabilities data to show.